– USA, CA – Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced the appointment of Will Febbo to its board of directors, effective March 28, 2022.
“We are extremely pleased to welcome Will to our board and leverage his depth of experience in building and managing technology and healthcare companies. We believe his experience in successfully leading OptimizeRx’s growth and expansion will bring a valuable perspective as we continue on our clear path to unlock the large market opportunity ahead,” said CEO, Manny Krakaris.
About William Febbo
For the last 20 years, Will Febbo has led health service, technology, and finance companies. He is currently CEO and Director of OptimizeRx (Nasdaq: OPRX) and continues to drive innovation in healthcare, leading the transformation of OptimizeRx into a leading digital health company that facilitates communication at the point of care for better health outcomes. Mr. Febbo previously served as COO of Investment Banking at Merriman Capital and CEO of Digital Capital Network, a wholly-owned subsidiary of Merriman Holdings. Before Merriman, Mr. Febbo was the CEO and Co-Founder of MedPanel, a market intelligence and communications provider to the life sciences and financial industries, which later was acquired by Merriman Capital. Mr. Febbo serves as a faculty member for the Massachusetts Institute of Technology linQ program, a collaborative initiative increasing the potential of innovative biomedical research to benefit society and the economy, and also serves on the board of the United Nations of Greater Boston.
“I am honored to join the Augmedix board. Augmedix has an impressive track record of advancing unique solutions for clinical documentation and addressing a significant burden for physicians and health systems. I am also impressed by Augmedix’s technology and progress toward generating a fully-automated medical note. I look forward to collaborating with this team to continue building on the company’s strong momentum and help to achieve its next chapter of growth,” said Will Febbo.
About Augmedix
Augmedix, Inc. provides automated medical documentation and data services to large healthcare systems and physician practices, supporting medical offices, clinics, hospitals, emergency departments, and telemedicine nationwide. The Company’s Ambient Automation Platform converts the natural conversation between physicians and patients into timely and comprehensive medical notes and performs a suite of related data services. These services relieve physicians of administrative burdens to enable more time for patient care. Augmedix’s proprietary platform uses automatic speech recognition, natural language processing, and clinical datasets to capture the ambient visit conversation and generate a structured medical note. The structured medical note data is then used to deliver additional data services. Quality is assured by trained medical documentation specialists.
For more information: https://augmedix.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.